Milton Costa
General Practice · Charleston, SCNPI 1629142674
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 263 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. Among general practice clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 263 payments — averaging $15.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$472
- Lilly USA, LLC$404
- Amgen$384
- AstraZeneca$346
- Boehringer Ingelheim$292
- Takeda Pharmaceuticals U.S.A., Inc.$247
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,065100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 34 | $472 |
| Lilly USA, LLC | 32 | $404 |
| Amgen(2 entities) | 24 | $384 |
| AstraZeneca | 24 | $346 |
| Boehringer Ingelheim | 19 | $292 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $247 |
| Pfizer | 11 | $169 |
| Johnson & Johnson | 11 | $156 |
| Esperion Therapeutics, Inc. | 10 | $148 |
| Novartis | 8 | $122 |
| Bayer | 6 | $114 |
| AbbVie(2 entities) | 6 | $108 |
| GSK | 7 | $106 |
| Biohaven Pharmaceuticals, Inc. | 6 | $105 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $90 |
| Sunovion Pharmaceuticals Inc. | 5 | $90 |
| Amarin Pharma, Inc. | 5 | $84 |
| Vanda Pharmaceuticals Inc. | 3 | $82 |
| Astellas Pharma US Inc | 4 | $78 |
| Abbott | 4 | $67 |
| Merck | 4 | $50 |
| Radius Health, Inc. | 2 | $46 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Eisai Inc. | 3 | $38 |
| Shire North American Group Inc | 2 | $29 |
| Optinose US, Inc. | 2 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Phadia US Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $14 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$4,065 in reported general payments places this provider in the 95th percentile of 1,367 general practice providers in South Carolina.
Other general practice in Charleston
- William BehlkeCharleston$38K
- Ashley HymanCharleston$8K
- Martin ToporekCharleston$7K
- James ThomasCharleston$6K
- Adam ForehandCharleston$5K
- Mary TatumCharleston$4K
- Joseph GrantSumter$187K
- Christopher CampbellLexington$166K
- Jeffrey HorowitzMurrells Inlet$152K
- Amanda SeayMount Pleasant$146K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.